rs113994123

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PP3_ModeratePP5

The NM_014694.4(ADAMTSL2):​c.340G>A​(p.Glu114Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,545,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

ADAMTSL2
NM_014694.4 missense

Scores

6
8
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:1O:1

Conservation

PhyloP100: 7.33

Publications

6 publications found
Variant links:
Genes affected
ADAMTSL2 (HGNC:14631): (ADAMTS like 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia. [provided by RefSeq, Feb 2009]
ADAMTSL2 Gene-Disease associations (from GenCC):
  • geleophysic dysplasia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 3 uncertain in NM_014694.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.907
PP5
Variant 9-133539801-G-A is Pathogenic according to our data. Variant chr9-133539801-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 695.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTSL2NM_014694.4 linkc.340G>A p.Glu114Lys missense_variant Exon 5 of 19 ENST00000651351.2 NP_055509.2 Q86TH1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTSL2ENST00000651351.2 linkc.340G>A p.Glu114Lys missense_variant Exon 5 of 19 NM_014694.4 ENSP00000498961.2 Q86TH1
ADAMTSL2ENST00000393061.7 linkc.667G>A p.Glu223Lys missense_variant Exon 5 of 19 1 ENSP00000376781.3 B1B0D4
ADAMTSL2ENST00000354484.8 linkc.340G>A p.Glu114Lys missense_variant Exon 5 of 19 1 ENSP00000346478.4 Q86TH1
ADAMTSL2ENST00000393060.1 linkc.340G>A p.Glu114Lys missense_variant Exon 5 of 19 1 ENSP00000376780.1 Q86TH1

Frequencies

GnomAD3 genomes
AF:
0.0000204
AC:
3
AN:
147210
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000501
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000150
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000641
AC:
1
AN:
155966
AF XY:
0.0000122
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000100
AC:
14
AN:
1398662
Hom.:
0
Cov.:
33
AF XY:
0.0000101
AC XY:
7
AN XY:
689854
show subpopulations
African (AFR)
AF:
0.0000633
AC:
2
AN:
31598
American (AMR)
AF:
0.00
AC:
0
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25182
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35736
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000834
AC:
9
AN:
1078922
Other (OTH)
AF:
0.00
AC:
0
AN:
57992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000204
AC:
3
AN:
147210
Hom.:
0
Cov.:
34
AF XY:
0.0000140
AC XY:
1
AN XY:
71662
show subpopulations
African (AFR)
AF:
0.0000501
AC:
2
AN:
39950
American (AMR)
AF:
0.00
AC:
0
AN:
14688
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4932
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4564
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10048
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
308
European-Non Finnish (NFE)
AF:
0.0000150
AC:
1
AN:
66456
Other (OTH)
AF:
0.00
AC:
0
AN:
1994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000144
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Geleophysic dysplasia 1 Pathogenic:3Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jun 17, 2017
Laboratory of Metabolic Disorders, Peking University First Hospital
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Jun 01, 2011
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1Uncertain:1
Oct 23, 2020
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 10, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21415077, 33082559, 30195254, 18677313, 28917829) -

Geleophysic dysplasia Pathogenic:1
Jun 21, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ADAMTSL2 c.340G>A (p.Glu114Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-06 in 155966 control chromosomes. c.340G>A has been reported in the literature in multiple individuals affected with Geleophysic Dysplasia as a homozygous, compound heterozygous, or unspecified genotype (e.g. Allali_2011, LeGoff_2008, Li_2017, Marzin_2021), including a de novo occurrence in a compound heterozygous individual (Li_2017). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21415077, 18677313, 28917829, 33082559). ClinVar contains an entry for this variant (Variation ID: 695). Based on the evidence outlined above, the variant was classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.072
T;T;T
Eigen
Uncertain
0.67
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.93
.;D;D
M_CAP
Uncertain
0.085
D
MetaRNN
Pathogenic
0.91
D;D;D
MetaSVM
Benign
-0.53
T
PhyloP100
7.3
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-2.2
N;N;N
REVEL
Uncertain
0.50
Sift
Uncertain
0.0070
D;D;D
Sift4G
Uncertain
0.013
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.92
MutPred
0.78
Gain of ubiquitination at E114 (P = 0.0177);.;Gain of ubiquitination at E114 (P = 0.0177);
MVP
0.80
MPC
1.1
ClinPred
0.99
D
GERP RS
5.5
Varity_R
0.38
gMVP
0.86
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113994123; hg19: chr9-136404923; API